Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial ; volume:23 ; number:1 ; day:4 ; month:11 ; year:2021 ; pages:1-10 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (4.11.2021), 1-10, 12.2021
- Creator
-
Lee, Sook Yan
Ibrahim, Fowzia
Tom, Brian D. M.
Nikiphorou, Elena
Williams, Frances M. K.
Lempp, Heidi
Scott, David L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02653-1
- URN
-
urn:nbn:de:101:1-2022011818111321160039
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Sook Yan
- Ibrahim, Fowzia
- Tom, Brian D. M.
- Nikiphorou, Elena
- Williams, Frances M. K.
- Lempp, Heidi
- Scott, David L.
- SpringerLink (Online service)
Other Objects (12)
Predictors of chronic migraine remission
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Rheumatoide Arthritis: Fatigue-Besserung folgt der Remission mit Verzögerung
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Illness progression in chronic fatigue syndrome: a shifting immune baseline
Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
Prevalence and predictors of fatigue after aneurysmal subarachnoid hemorrhage
Predictors of chronic migraine remission
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Rheumatoide Arthritis: Fatigue-Besserung folgt der Remission mit Verzögerung
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Illness progression in chronic fatigue syndrome: a shifting immune baseline
Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
Prevalence and predictors of fatigue after aneurysmal subarachnoid hemorrhage
Predictors of chronic migraine remission
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
Rheumatoide Arthritis: Fatigue-Besserung folgt der Remission mit Verzögerung
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Illness progression in chronic fatigue syndrome: a shifting immune baseline
Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
Defining and characterizing sustained remission in patients with rheumatoid arthritis
The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study